NCT02183285View on ClinicalTrials.gov

Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Pharmaton PHL 00747 soft gelatine capsules

DIETARY_SUPPLEMENT

Pharmaton PHL 00747 film-coated tablets

DIETARY_SUPPLEMENT

Placebo film-coated tablets (fct)

DIETARY_SUPPLEMENT

Placebo soft gelatine capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183285 - Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential | Biotech Hunter | Biotech Hunter